HKSE - Delayed Quote • HKD
Sinohealth Holdings Limited (2361.HK)
At close: April 26 at 2:34 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
396,194.000
396,194.000
356,668.000
324,166.000
202,073.000
Cost of Revenue
172,722.000
172,722.000
197,560.000
131,527.000
71,867.000
Gross Profit
223,472.000
223,472.000
159,108.000
192,639.000
130,206.000
Operating Expense
116,471.000
116,471.000
125,687.000
106,306.000
67,817.000
Operating Income
107,001.000
107,001.000
33,421.000
86,333.000
62,389.000
Net Non Operating Interest Income Expense
26,028.000
26,028.000
6,203.000
-284.000
3,959.000
Pretax Income
110,741.000
110,741.000
54,474.000
95,529.000
76,072.000
Tax Provision
9,801.000
9,801.000
261.000
23,551.000
10,743.000
Net Income Common Stockholders
102,032.000
102,032.000
55,758.000
78,813.000
67,926.000
Diluted NI Available to Com Stockholders
102,032.000
102,032.000
55,758.000
78,813.000
67,926.000
Basic EPS
0.24
--
0.14
0.21
0.15
Diluted EPS
0.24
--
0.14
0.21
0.15
Basic Average Shares
426,125.312
--
410,666.838
373,123.325
450,000.000
Diluted Average Shares
426,125.312
--
410,666.838
373,123.325
450,000.000
Rent Expense Supplemental
126.000
126.000
66.000
364.000
--
Total Expenses
289,193.000
289,193.000
323,247.000
237,833.000
139,684.000
Net Income from Continuing & Discontinued Operation
102,032.000
102,032.000
55,758.000
78,813.000
67,926.000
Normalized Income
123,500.626
123,500.626
49,409.900
71,442.636
59,646.099
Interest Income
26,668.000
26,668.000
6,615.000
248.000
5,181.000
Interest Expense
640.000
640.000
412.000
532.000
1,222.000
Net Interest Income
26,028.000
26,028.000
6,203.000
-284.000
3,959.000
EBIT
111,381.000
111,381.000
54,886.000
96,061.000
77,294.000
EBITDA
119,947.000
119,947.000
63,615.000
103,413.000
85,177.000
Reconciled Cost of Revenue
172,722.000
172,722.000
197,560.000
131,527.000
71,867.000
Reconciled Depreciation
8,566.000
8,566.000
8,729.000
7,352.000
7,883.000
Net Income from Continuing Operation Net Minority Interest
102,032.000
102,032.000
55,758.000
78,813.000
67,926.000
Total Unusual Items Excluding Goodwill
-23,566.000
-23,566.000
6,380.000
9,788.000
9,639.000
Total Unusual Items
-23,566.000
-23,566.000
6,380.000
9,788.000
9,639.000
Normalized EBITDA
143,513.000
143,513.000
57,235.000
93,625.000
75,538.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
-2,097.374
-2,097.374
31.900
2,417.636
1,359.099
12/31/2020 - 7/12/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade